Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
PolyPid
277
PolyPid
Technology
Biotechnology
PolyPid is a clinical stage emerging specialty pharmaceutical company, engaged in research and development of products based on PLEX (PolymerLipid Encapsulation MatriX), a proprietary drug delivery technology.
Suggest edits
Raised
$35.4M
Follow us
Companies in the same industry
Eyevensys
Leukos Biotech
laboratoire MédiS
Antibodies.com
Patara Pharma, LLC
ADC Therapeutics
Vivo Biosciences Inc.
Paradigm Diagnostics
AudioCure Pharma GmbH
Immagina Biotechnology
Alexa global traffic share
Overview
Funding
3
Add info
Latest funding
Show all
$5,300,000
Venture capital (Series UNDISCLOSED) - 2016
$22,000,000
Venture capital (Series D) - 2016
Aurum Ventures
Shavit Capital
Chaim Hurvitz
Team Size
10+
Employees
I work here
Location
Israel
Headquarters
Explore Israel
PE HUB
,
FinSMEs
PolyPid raises $50 mln
$22,000,000
Venture capital (Series D)
FinSMEs
,
NoCamels - Israeli Tech and Innovation News
PolyPid Closes $22M Equity Financing
Health
Funding
